Please login to the form below

lurasidone

This page shows the latest lurasidone news and features for those working in and with pharma, biotech and healthcare.

Takeda and development partner Dainippon Sumitomo Pharma have won European approval for their schizophrenia treatment Latuda (lurasidone).

GSK's diabetes drug among CHMP recommendations

2013. Takeda's antipsychotic and Linepharma's Hemoprostol. Elsewhere in the CHMP opinions, Takeda received a recommendation for the use of Latuda (lurasidone) in the treatment of adults with schizophrenia.
Schizophrenia treatments

Lurasidone, an antagonist of dopamine D2, serotonin 2A, serotonin 7, serotonin 2C and a partial agonist of serotonin 1A, is being marketed by Sunovion Pharmaceuticals.
Coronary conundrums

US. Lurasidone. Latuda (Sunovion Pharmaceuticals). Schizophrenia. US an Puerto Rico. Paracetamol.
DSP buys Sepracor

The move comes as DSP prepares to launch its schizophrenia drug lurasidone, which last month significantly outperformed placebo in late-stage trials. ... The acquisition gives DSP the sales and marketing infrastructure in the US it needs to commercialise

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Interview: Trevor Smith, Takeda

There's prostate cancer drug orteronel (TAK-700) and vedolizumab for Crohn's disease and ulcerative colitis, and then the atypical antipsychotic lurasidone. ... From among its product pipeline Smith picks prostate cancer drug orteronel (TAK-700),

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Senior Account Director development role to Business Director, H...: Excellent package

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Senior Account Manager / Account Director - Med Comms: Great salary and benefits

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Lead Medical Copywriter, Healthcare Brand Communications, London: Excellent package

Add my company

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Tackling a formidable foe: Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Cancer care – the power of new technologies: With patient numbers set to soar, how can we make a difference?...
Redefining communications excellence: How to be heard in today’s multichannel, multistakeholder, multimedia world...